TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TEVA

Teva Pharma Industries Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

39.20$ -2.6% vs. previous close Closing price · As of: Sep 25, 2026

Investor relations

Report Dates

Investor relations overview for Teva Pharma Industries Ltd (TEVA): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 07/29/2026
Earnings surprise by quarter (%)
Q3 23 · -1.6 % 23 Q4 23 · 31.6 % 23 Q1 24 · -5.9 % 24 Q2 24 · 10.9 % 24 Q3 24 · 4.6 % 24 Q4 24 · 1.4 % 24 Q1 25 · 13.0 % 25 Q2 25 · 6.5 % 25 Q3 25 · 13.6 % 25 Q4 25 · 50.0 % 25 Q1 26 · 15.2 % 26 Q2 26 · 1,180.0 % 26

EPS estimate beaten

Full history 76 of 123 quarters (62%)
Last 16 quarters 11 of 16 quarters (69%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/16/2026 TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/14/2026 TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Other Events · sec.gov Open ↗
  • 09/11/2026 TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/03/2026 TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/03/2026 TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Material Modifications to Rights of Security Holders; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?